Neutrophil myeloperoxidase and its substrates: Formation of specific markers and reactive compounds during inflammation

Journal of Clinical Biochemistry and Nutrition

Volumn 58, Issue 2, 2016, Pages 99-104

  Kato, Yoji ^a  

^a UNIVERSITY OF HYOGO   (Japan)

Author keywords

Hypochlorous acid; Inflammatory damage; Myeloperoxidase; Phytochemicals

Indexed keywords

3 NITROTYROSINE; 8 HYDROXYDEOXYGUANOSINE; BIOLOGICAL MARKER; CERULOPLASMIN; CHOLESTEROL; CURCUMIN; EOSINOPHIL PEROXIDASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; HORSERADISH PEROXIDASE; INDUCIBLE NITRIC OXIDE SYNTHASE; ISONIAZID; LEPTOSPERIN; METHIONINE; MYELOPEROXIDASE; NITRIC OXIDE; NUCLEIC ACID; OXIDOREDUCTASE INHIBITOR; PARACETAMOL; PEROXYNITRITE; PLANT MEDICINAL PRODUCT; POLYPHENOL DERIVATIVE; PROTEIN; QUERCETIN; REACTIVE OXYGEN METABOLITE; SEROTONIN; SUPEROXIDE; THIOL; TYROSINE; UNCLASSIFIED DRUG; URATE;

ANTIINFLAMMATORY ACTIVITY; BACTERICIDAL ACTIVITY; CARDIOVASCULAR DISEASE; COPRINUS COMATUS; ENZYME INHIBITION; EXTRACELLULAR TRAP; FIBROBLAST; HOST RESISTANCE; HUMAN; INFLAMMATION; LIPID OXIDATION; MOLECULAR WEIGHT; NEUTROPHIL; NONHUMAN; REVIEW; TISSUE INJURY; VEGETABLE;

EID: 84959560742     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.15-104     Document Type: Review

References (64)

1. Senthilmohan R, Kettle AJ. Bromination and chlorination reactions of myeloperoxidase at physiological concentrations of bromide and chloride. Arch Biochem Biophys 2006; 445: 235-244.
2. Wang Z, Nicholls SJ, Rodriguez ER, et al. Protein carbamylation links inflammation, smoking, uremia and atherogenes is. Nat Med 2007; 13: 1176-1184.
3. Ximenes VF, Maghzal GJ, Turner R, Kato Y, Winterbourn CC, Kettle AJ. Serotonin as a physiological substrate for myeloperoxidase and its superoxide-dependent oxidation to cytotoxic tryptamine-4,5-dione. Biochem J 2009; 425: 285-293.
4. DeNichilo MO, Panagopoulos V, Rayner TE, Borowicz RA, Greenwood JE, Evdokiou A. Peroxidase enzymes regulate collagen extracellular matrix biosynthesis. Am J Pathol 2015; 185: 1372-1384.
5. Panagopoulos V, Zinonos I, Leach DA, et al. Uncovering a new role for peroxidase enzymes as drivers of angiogenesis. Int J Biochem Cell Biol 2015; 68: 128-138.
6. Binsack R, Boersma BJ, Patel RP, et al. Enhanced antioxidant activity after chlorination of quercetin by hypochlorous acid. Alcohol Clin Exp Res 2001; 25: 434-443.
7. Parker H, Winterbourn CC. Reactive oxidants and myeloperoxidase and their involvement in neutrophil extracellular traps. Front Immunol 2013; 3: 424.
8. Wu W, Chen Y, d'Avignon A, Hazen SL. 3-Bromotyrosine and 3,5-dibromotyrosine are major products of protein oxidation by eosinophil peroxidase: potential markers for eosinophil-dependent tissue injury in vivo. Biochemistry 1999; 38: 3538-3548.
9. Fu S, Wang H, Davies M, Dean R. Reactions of hypochlorous acid with tyrosine and peptidyl-tyrosyl residues give dichlorinated and aldehydic products in addition to 3-chlorotyrosine. J Biol Chem 2000; 275: 10851-10858.
10. Chapman AL, Senthilmohan R, Winterbourn CC, Kettle AJ. Comparison of mono- and dichlorinated tyrosines with carbonyls for detection of hypochlorous acid modified proteins. Arch Biochem Biophys 2000; 377: 95-100.
11. Ishitsuka Y, Maniwa F, Koide C, et al. Increased halogenated tyrosine levels are useful markers of human skin ageing, reflecting proteins denatured by past skin inflammation. Clin Exp Dermatol 2012; 37: 252-258.
12. Sampson JB, Ye Y, Rosen H, Beckman JS. Myeloperoxidase and horseradish peroxidase catalyze tyrosine nitration in proteins from nitrite and hydrogen peroxide. Arch Biochem Biophys 1998; 356: 207-213.
13. Koyani CN, Flemmig J, Malle E, Arnhold J. Myeloperoxidase scavenges peroxynitrite: a novel anti-inflammatory action of the heme enzyme. Arch Biochem Biophys 2015; 571: 1-9.
14. Curtis MP, Neidigh JW. Kinetics of 3-nitrotyrosine modification on exposure to hypochlorous acid. Free Radic Res 2014; 48: 1355-1362.
15. Yuan W, Wang Y, Heinecke JW, Fu X. Hypochlorous acid converts the gamma-glutamyl group of glutathione disulfide to 5-hydroxybutyrolactam, a potential marker for neutrophil activation. J Biol Chem 2009; 284: 26908-26917.
16. Harwood DT, Kettle AJ, Winterbourn CC. Production of glutathione sulfonamide and dehydroglutathione from GSH by myeloperoxidase-derived oxidants and detection using a novel LC-MS/MS method. Biochem J 2006; 399: 161-168.
17. Henderson JP, Byun J, Heinecke JW. Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes produces 5-chlorocytosine in bacterial RNA. J Biol Chem 1999; 274: 33440-33448.
18. Kawai Y, Morinaga H, Kondo H, et al. Endogenous formation of novel halogenated 2′-deoxycytidine. Hypohalous acid-mediated DNA modification at the site of inflammation. J Biol Chem 2004; 279: 51241-51249.
19. Masuda M, Suzuki T, Friesen MD, et al. Chlorination of guanosine and other nucleosides by hypochlorous acid and myeloperoxidase of activated human neutrophils. Catalysis by nicotine and trimethylamine. J Biol Chem 2001; 276: 40486-40496.
20. Henderson JP, Byun J, Williams MV, et al. Bromination of deoxycytidine by eosinophil peroxidase: a mechanism for mutagenesis by oxidative damage of nucleotide precursors. Proc Natl Acad Sci U S A 2001; 98: 1631-1636.
21. Asahi T, Kondo H, Masuda M, et al. Chemical and immunochemical detection of 8-halogenated deoxyguanosines at early stage inflammation. J Biol Chem 2010; 285: 9282-9291.
22. Sassa A, Kamoshita N, Matsuda T, et al. Miscoding properties of 8-chloro-2′-deoxyguanosine, a hypochlorous acid-induced DNA adduct, catalysed by human DNA polymerases. Mutagenesis 2013; 28: 81-88.
23. Sassa A, Ohta T, Nohmi T, Honma M, Yasui M. Mutational specificities of brominated DNA adducts catalyzed by human DNA polymerases. J Mol Biol 2011; 406: 679-686.
24. Asahi T, Wu X, Shimoda H, et al. A mushroom-derived amino acid, ergothioneine, is a potential inhibitor of inflammation-related DNA halogenation. Biosci Biotechnol Biochem 2015. DOI: 10.1080/09168451.2015.1083396
25. Suzuki T, Kosaka A, Inukai M. Formation of 8-S-L-cysteinylguanosine from 8-bromoguanosine and cysteine. Bioorg Med Chem Lett 2013; 23: 3864-3867.
26. Sawa T, Zaki MH, Okamoto T, et al. Protein S-guanylation by the biological signal 8-nitroguanosine 3′,5′-cyclic monophosphate. Nat Chem Biol 2007; 3: 727-735.
27. Asahi T, Nakamura Y, Kato Y, Osawa T. Specific role of taurine in the 8-brominated-2′-deoxyguanosine formation. Arch Biochem Biophys 2015; 586: 45-50.
28. Heinecke JW, Li W, Mueller DM, Bohrer A, Turk J. Cholesterol chlorohydrin synthesis by the myeloperoxidase-hydrogen peroxide-chloride system: potential markers for lipoproteins oxidatively damaged by phagocytes. Biochemistry 1994; 33: 10127-10136.
29. van den Berg JJ, Winterbourn CC, Kuypers FA. Hypochlorous acid-mediated modification of cholesterol and phospholipid: analysis of reaction products by gas chromatography-mass spectrometry. J Lipid Res 1993; 34: 2005-2012.
30. Winterbourn CC, Kettle AJ. Biomarkers of myeloperoxidase-derived hypochlorous acid. Free Radic Biol Med 2000; 29: 403-409.
31. Kawai Y, Kiyokawa H, Kimura Y, Kato Y, Tsuchiya K, Terao J. Hypochlorous acid-derived modification of phospholipids: characterization of aminophospholipids as regulatory molecules for lipid peroxidation. Biochemistry 2006; 45: 14201-14211.
32. Jacob JS, Cistola DP, Hsu FF, et al. Human phagocytes employ the myeloperoxidase-hydrogen peroxide system to synthesize dityrosine, trityrosine, pulcherosine, and isodityrosine by a tyrosyl radical-dependent pathway. J Biol Chem 1996; 271: 19950-19956.
33. Leeuwenburgh C, Rasmussen JE, Hsu FF, Mueller DM, Pennathur S, Heinecke JW. Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques. J Biol Chem 1997; 272: 3520-3526.
34. Hallingback HR, Gabdoulline RR, Wade RC. Comparison of the binding and reactivity of plant and mammalian peroxidases to indole derivatives by computational docking. Biochemistry 2006; 45: 2940-2950.
35. Wrona MZ, Dryhurst G. Interactions of 5-hydroxytryptamine with oxidative enzymes. Biochem Pharmacol 1991; 41: 1145-1162.
36. Jiang XR, Dryhurst G. Inhibition of the alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase complexes by a putative aberrant metabolite of serotonin, tryptamine-4,5-dione. Chem Res Toxicol 2002; 15: 1242-1247.
37. Kato Y, Ono S, Kitamoto N, Kettle AJ. Covalent modification of cytoskeletal proteins in neuronal cells by tryptamine-4,5-dione. Redox Biol 2014; 2C: 983-990.
38. Meotti FC, Jameson GN, Turner R, et al. Urate as a physiological substrate for myeloperoxidase: implications for hyperuricemia and inflammation. J Biol Chem 2011; 286: 12901-12911.
39. Davies MJ. Myeloperoxidase-derived oxidation: mechanisms of biological damage and its prevention. J Clin Biochem Nutr 2011; 48: 8-19.
40. Kato Y, Dozaki N, Nakamura T, et al. Quantification of modified tyrosines in healthy and diabetic human urine using liquid chromatography/tandem mass spectrometry. J Clin Biochem Nutr 2009; 44: 67-78.
41. 2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins. Eur J Biochem 2000; 267: 4495-4503.
42. Malle E, Hazell L, Stocker R, Sattler W, Esterbauer H, Waeg G. Immunologic detection and measurement of hypochlorite-modified LDL with specific monoclonal antibodies. Arterioscler Thromb Vasc Biol 1995; 15: 982-989.
43. Gröne HJ, Gröne EF, Malle E. Immunohistochemical detection of hypochlorite-modified proteins in glomeruli of human membranous glomerulonephritis. Lab Invest 2002; 82: 5-14.
44. Carr AC, Vissers MC, Domigan NM, Winterbourn CC. Modification of red cell membrane lipids by hypochlorous acid and haemolysis by preformed lipid chlorohydrins. Redox Rep 1997; 3: 263-271.
45. Gujral JS, Hinson JA, Jaeschke H. Chlorotyrosine protein adducts are reliable biomarkers of neutrophil-induced cytotoxicity in vivo. Comp Hepatol 2004; 3 (Suppl 1): S48.
46. Kambayashi Y, Ogino K, Takemoto K, et al. Preparation and characterization of a polyclonal antibody against brominated protein. J Clin Biochem Nutr 2009; 44: 95-103.
47. Kato Y, Kawai Y, Morinaga H, et al. Immunogenicity of a brominated protein and successive establishment of a monoclonal antibody to dihalogenated tyrosine. Free Radic Biol Med 2005; 38: 24-31.
48. Robaszkiewicz A, Bartosz G, Soszynski M. Detection of 3-chlorinated tyrosine residues in human cells by flow cytometry. J Immunol Methods 2011; 369: 141-145.
49. Kawai Y, Matsui Y, Kondo H, et al. Galloylated catechins as potent inhibitors of hypochlorous acid-induced DNA damage. Chem Res Toxicol 2008; 21: 1407-1414.
50. Chapman AL, Mocatta TJ, Shiva S, et al. Ceruloplasmin is an endogenous inhibitor of myeloperoxidase. J Biol Chem 2013; 288: 6465-6477.
51. Paumann-Page M, Furtmüller PG, Hofbauer S, Paton LN, Obinger C, Kettle AJ. Inactivation of human myeloperoxidase by hydrogen peroxide. Arch Biochem Biophys 2013; 539: 51-62.
52. Forbes LV, Furtmüller PG, Khalilova I, Turner R, Obinger C, Kettle AJ. Isoniazid as a substrate and inhibitor of myeloperoxidase: identification of amine adducts and the influence of superoxide dismutase on their formation. Biochem Pharmacol 2012; 84: 949-960.
53. Forbes LV, Sjogren T, Auchère F, et al. Potent reversible inhibition of myeloperoxidase by aromatic hydroxamates. J Biol Chem 2013; 288: 36636-36647.
54. Koelsch M, Mallak R, Graham GG, et al. Acetaminophen (paracetamol) inhibits myeloperoxidase-catalyzed oxidant production and biological damage at therapeutically achievable concentrations. Biochem Pharmacol 2010; 79: 1156-1164.
55. Zhang H, Jing X, Shi Y, et al. N-acetyl lysyltyrosylcysteine amide inhibits myeloperoxidase, a novel tripeptide inhibitor. J Lipid Res 2013; 54: 3016-3029.
56. Kato Y, Nagao A, Terao J, Osawa T. Inhibition of myeloperoxidase-catalyzed tyrosylation by phenolic antioxidants in vitro. Biosci Biotechnol Biochem 2003; 67: 1136-1139.
57. Shiba Y, Kinoshita T, Chuman H, et al. Flavonoids as substrates and inhibitors of myeloperoxidase: molecular actions of aglycone and metabolites. Chem Res Toxicol 2008; 21: 1600-1609.
58. Franck T, Kohnen S, Grulke S, et al. Inhibitory effect of curcuminoids and tetrahydrocurcuminoids on equine activated neutrophils and myeloperoxidase activity. Physiol Res 2008; 57: 577-587.
59. Meotti FC, Senthilmohan R, Harwood DT, Missau FC, Pizzolatti MG, Kettle AJ. Myricitrin as a substrate and inhibitor of myeloperoxidase: implications for the pharmacological effects of flavonoids. Free Radic Biol Med 2008; 44: 109-120.
60. Kato Y, Umeda N, Maeda A, Matsumoto D, Kitamoto N, Kikuzaki H. Identification of a novel glycoside, leptosin, as a chemical marker of manuka honey. J Agric Food Chem 2012; 60: 3418-3423.
61. Molan P, Rhodes T. Honey: a biologic wound dressing. Wounds 2015; 27: 141-151.
62. Prakash A, Medhi B, Avti PK, Saikia UN, Pandhi P, Khanduja KL. Effect of different doses of Manuka honey in experimentally induced inflammatory bowel disease in rats. Phytother Res 2008; 22: 1511-1519.
63. Kato Y, Fujinaka R, Ishisaka A, Nitta Y, Kitamoto N, Takimoto Y. Plausible authentication of manuka honey and related products by measuring leptosperin with methyl syringate. J Agric Food Chem 2014; 62: 6400-6407.
64. Kato Y, Araki Y, Juri M, et al. Immunochemical authentication of manuka honey using a monoclonal antibody specific to a glycoside of methyl syringate. J Agric Food Chem 2014; 62: 10672-10678.